November 14, 2016

Meeting Registration is now OPEN!
We hope you can join us for the NRG Oncology Semiannual Meeting, February 9-12, 2017 at the Marriott Marquis Houston in Houston, TX. Registration deadline is January 10, 2017. Please pre-register online for this meeting before the January 10, 2017 deadline! Registering onsite at the meeting will incur an additional $50 fee. Registration and meeting information is available on the NRG Oncology website.

AMENDMENTS AND UPDATES
BREAST
RTOG 1119: Amendments 5, 6 and 7, version date: October 17, 2016 have been approved by Health Canada. Sites in Canada can find the NOL and required TPD forms on the CTSU website.

HEAD & NECK
RTOG 0912: Amendments 11-12, version dates: September 13, 2016, and October 21, 2016; also available on the CTSU website.

FORM UPDATES
CANCER CONTROL
NRG-CC001
: Neurocognitive Training Letter has been modified. It is currently on the NRG Oncology website.

NRG-CC003: Neurocognitive Training Letter has been modified. It is on the CTSU website. All certified RAs should review.

OTHER PROTOCOL NOTICES
GYNECOLOGIC
GOG-0274/RTOG 1174: OUTBACK Biannual Progress Report October 2016.

CANCER CONTROL
NRG-CC001
: Email notification for Step 2 registration will take 1 business day (24 hours) once the baseline neurocognitive assessments are uploaded because the baseline needs to be reviewed for completeness and scored.

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, and NRG-CC003. Space is limited so register now and reserve your seat. The next webinar training is scheduled for November 16, 2016.

DRUG SAFETY UPDATES AND INVESTIGATOR BROCHURE (IB) NOTICES
Safety updates have been issued for NSABP legacy studies. For details, please see the NSABP E-mail Distributions page and the CTSU website.

An Investigator’s Brochure notice has been issued for the following NRG studies:
Nivolumab (NRG-GY002, NRG-GY003, and NRG-BN002)

The current version of the Investigator Brochure Documents (IB-Summary of Changes) for Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI)-sponsored trials is available for access via the Cancer Therapy Evaluation Program (CTEP) Online Agent Order Processing (OAOP) website ( https://eapps-ctep.nci.nih.gov/OAOP/pages/login.jspx). Log-in using your Identity and Access Management (IAM) username and password credentials and provide the requested information to access the document.

Thanksgiving Day holiday closures
Thanksgiving Day holiday closure information for the NRG Oncology Operations Offices, Statistics and Data Management Centers (SDMCs), and Biospecimen Banks is posted on the NRG Oncology website under "News; 2016 Announcements."

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

MANUSCRIPT SUBMISSION TO THE NIH MANUSCRIPT SUBMISION (NIHMS) SYSTEM
All corresponding authors of manuscripts resulting from NIH-funded work are required by the NIH to submit a record of their publication to the NIHMS system. For the convenience of our research authors, we provide this link to help you better understand the process: https://www.nrgoncology.org/Portals/0/Publications/PMC%20Submission%20Methods%20Flow%20Chart%2011-7-2016.pdf
Note that of the 4 possible methods for recording publications, Method D is that which will be used most often by our researchers.

JOURNAL ARTICLES
Al-Hallaq HA, Chmura S, Salama JK, Winter KA, Robinson CG, Pisansky TM, Borges V, Lowenstein JR, McNulty S, Galvin JM, Followill DS, Timmerman RD, White JR, Xiao Y, Matuszak MM. Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases. Pract Radiat Oncol. 2016 Nov - Dec;6(6):e291-e298. doi: 10.1016/j.prro.2016.05.004. PubMed PMID: 27345129. Read more

Hibler EA, Kauderer J, Greene MH, Rodriguez GC, Alberts DS. Bone loss after oophorectomy among high-risk women: An NRG oncology/gynecologic oncology group study. Menopause. 2016 Nov;23(11):1228-1232. PubMed PMID: 27433858; PubMed Central PMCID: PMC5079806. Read more

Moore KN, Java JJ, Slaughter KN, Rose PG, Lanciano R, DiSilvestro PA, Thigpen JT, Lee YC, Tewari KS, Chino J, Seward SM, Miller DS, Salani R, Moore DH, Stehman FB. Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis. Gynecol Oncol. 2016 Nov;143(2):294-301. doi: 10.1016/j.ygyno.2016.08.317. PubMed PMID: 27542967. Read more

UPCOMING PRESENTATIONS
Society for Neuro-Oncology (SNO) meeting November 17-20, 2016
Bell EH, Zhang P, Fisher BJ, Macdonald DR, McElroy JP, Lesser GJ, Fleming J, Chakraborty A, Liu Z, Becker AP, Fabian D, Aldape KD, Ashby LS, Werner-Wasik M, Walker EM, Bahary J, Kwok Y, Yu HM, Laack NN, Schultz CJ, Gray HJ, Robins HI, Mehta MP, Chakravarti A. MGMT status predicts survival outcomes in NRG Oncology/RTOG 0424: a phase II trial of temozolomide-based chemoradiotherapy for high risk low-grade gliomas. Abstract MPTH-4. Poster

Bell EH, Zhang P, Shaw EG, Buckner JC, Barger GR, Coons SW, Bullard DE, Mehta MP, Gilbert MR, Brown PD, Stelzer KJ, McElroy JP, Fleming J, Chakraborty A, Becker AP, Aldape KD, Brachman DG, Murtha AD, Schultz CJ, Johnson D, Gertler SZ, Laack NN, Werner-Wasik M, Crocker IR, Chakravarti A. 1p/19q co-deletion status predicts survival outcomes in NRG Oncology/RTOG 9802: A phase III trial of RT vs RT + PCV in high risk low-grade gliomas. Soc Neuro Oncol. Abstr MPTH-06. Poster

Peereboom DM, Moughan J, Kim I, De Los Santos JF, Sperduto PW, White JR, Mehta MP. NRG oncology RTOG 1119: Phase II randomized study of whole brain radiotherapy with concurrent lapatinib in patients with brain metastasis from Her2-positive breast cancer: A collaborative study of NRG and KROG. Poster

Vera-Bolanos E, Scheurer M, Zhou R, Gilbert MR, Bondy ML, Sulman EP, Yuan Y, Liu Y, Wendland MM, Brachman DG, Bearden JD III, McGovern SL, Wilson SS, Judy KD, Robins HI, Hunter GK, Crocker IR, Chao ST, Kaluza V, Pugh SL, Armstrong TS. Occurrence and implications of myelosuppression during concurrent therapy on NRG Oncology RTOG 0825. Abstract ACTR-21. Poster

PUBLICATIONS REMINDERS
Please note the following upcoming meeting and abstract submission deadline dates.
Upcoming Meetings
Radiological Society of North America (RSNA); Nov 27-Dec 2, 2016; Chicago, IL
Society for Neuro-Oncology (SNO); Nov 17-20, 2016; Scottsdale, AZ
San Antonio Breast Cancer Symposium (SABCS); Dec 6-10, 2016; San Antonio, TX

Upcoming abstract submission deadlines
American Association for Cancer Research (AACR); Apr 1-5, 2017; Washington, DC; meeting abstracts submission deadline Nov 17, 2016

American College of Radiology (ACR); May 21-25, 2017; Washington, DC; due to publications committee Dec 2, 2016; meeting abstracts submission deadline Dec 16, 2016

American Radium Society (ARS); May 6-9, 2017; Colorado Springs, CO; meeting abstracts submission deadline Nov 18, 2016

American Society of Colon and Rectal Surgeons (ASCRS); Jun 10-14, 2017; Seattle, WA; due to publications committee Nov 15, 2016; meeting abstracts submission deadline Nov 29, 2016

Digestive Disease Week (DDW); May 6-9, 2017; Chicago, IL; due to publications committee Nov 17, 2016; meeting abstracts submission deadline Dec 1, 2016

Society of Gynecologic Oncology (SGO); Mar 12-15, 2017; National Harbor, MD; meeting abstracts submission deadline Dec 31, 2016 Global session; Dec 5-Jan 8, 2017 LBA

St. Gallen Breast Cancer Conference; Mar 15-18, 2017; Vienna, Austria; due to publications committee Dec 1, 2016; meeting abstracts submission deadline Dec 15, 2016

NRG Oncology is proud to be an active participant of #CancerMoonShot.

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address